Sera Prognostics, Inc. (SERA) Revenue Growth
Sera Prognostics, Inc. (SERA) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | 226.83% |
| 2023-12-31 | 14.18% |
| 2024-12-31 | -74.84% |
| 2025-12-31 | 5.19% |
How SERA compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| INCY | Incyte Corporation | 21.22% |
| RARE | Ultragenyx Pharmaceutical Inc. | 20.18% |
| TFX | Teleflex Incorporated | 17.25% |
| AGEN | Agenus Inc. | 10.37% |
| QTRX | Quanterix Corporation | 1.07% |
These are five companies in the same sector as SERA with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sera Prognostics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("SERA", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SERA | $2.01 | -3.37% | 0.02M |
| 3 | ||||
| 4 | ||||
| 5 |